End of this week we could get an approval or more delays. No guarantee SP will move on an approval as the sales part of this company are rather slow on the uptake so an approval is no given for increased sales. Great medical application, it works and has DVA approvals so is it worth the risk and buying more on a slow uptake? Think I will wait and if approved and SP remains flat will buy more otherwise bye bye bargain.
Ann: AVITA Medical to Announce First Quarter 2024 Results, page-146
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.98 |
Change
-0.070(2.30%) |
Mkt cap ! $203.6M | |||
| Open | High | Low | Value | Volume |
| $3.03 | $3.03 | $2.96 | $258.0K | 86.53K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2868 | $2.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.98 | 3362 | 4 |
View Market Depth
| Last trade - 14.18pm 30/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |